Fortrea (FTRE) to Release Earnings on Wednesday

Fortrea (NASDAQ:FTRE) is expected to release its Q3 2025 results before the market opens on Wednesday, November 5th. Analysts expect Fortrea to post earnings of $0.16 per share and revenue of $643.4290 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q3 2025 earningreport page for the latest details on the call scheduled for Wednesday, November 5, 2025 at 8:00 AM ET.

Fortrea (NASDAQ:FTRE) last announced its quarterly earnings data on Friday, May 24th. The company reported $0.37 earnings per share for the quarter. The company had revenue of $693.90 million during the quarter. Fortrea had a positive return on equity of 5.25% and a negative net margin of 37.57%. On average, analysts expect Fortrea to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Fortrea Stock Up 0.1%

Shares of NASDAQ FTRE traded up $0.01 during mid-day trading on Monday, hitting $10.47. The company had a trading volume of 69,915 shares, compared to its average volume of 2,123,035. The company has a market capitalization of $950.68 million, a PE ratio of -0.91, a price-to-earnings-growth ratio of 0.46 and a beta of 1.81. The firm has a 50-day simple moving average of $9.91 and a two-hundred day simple moving average of $7.13. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 1.87. Fortrea has a one year low of $3.97 and a one year high of $25.28.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the company. Robert W. Baird upped their price objective on Fortrea from $9.00 to $14.00 and gave the company an “outperform” rating in a report on Wednesday, September 3rd. Baird R W upgraded Fortrea from a “hold” rating to a “strong-buy” rating in a research note on Monday, August 4th. Barclays boosted their price target on Fortrea from $6.00 to $8.00 and gave the company an “underweight” rating in a research note on Thursday, October 2nd. Weiss Ratings reiterated a “sell (d-)” rating on shares of Fortrea in a research note on Wednesday, October 8th. Finally, Jefferies Financial Group upped their target price on Fortrea from $7.00 to $9.50 and gave the stock a “hold” rating in a research note on Tuesday, September 9th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, ten have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $12.39.

Insider Activity

In other news, Director Erin L. Russell purchased 9,854 shares of the company’s stock in a transaction dated Tuesday, September 2nd. The stock was bought at an average cost of $10.15 per share, for a total transaction of $100,018.10. Following the purchase, the director owned 9,854 shares of the company’s stock, valued at approximately $100,018.10. The trade was a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Peter M. Neupert purchased 32,500 shares of the company’s stock in a transaction dated Monday, August 11th. The stock was purchased at an average price of $6.26 per share, with a total value of $203,450.00. Following the completion of the purchase, the director directly owned 98,132 shares in the company, valued at $614,306.32. The trade was a 49.52% increase in their position. The SEC filing for this purchase provides additional information. In the last ninety days, insiders bought 72,354 shares of company stock worth $507,168 and sold 10,311 shares worth $94,635. 0.38% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Fortrea

A number of hedge funds have recently made changes to their positions in FTRE. Osaic Holdings Inc. grew its stake in Fortrea by 74.3% in the second quarter. Osaic Holdings Inc. now owns 6,844 shares of the company’s stock valued at $38,000 after acquiring an additional 2,918 shares during the period. Tower Research Capital LLC TRC boosted its stake in Fortrea by 137.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 8,713 shares of the company’s stock valued at $43,000 after purchasing an additional 5,036 shares during the last quarter. EverSource Wealth Advisors LLC boosted its stake in Fortrea by 662.9% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 11,963 shares of the company’s stock valued at $59,000 after purchasing an additional 10,395 shares during the last quarter. Franklin Resources Inc. acquired a new position in Fortrea during the 2nd quarter valued at about $60,000. Finally, M&T Bank Corp acquired a new position in Fortrea during the 2nd quarter valued at about $64,000.

Fortrea Company Profile

Fortrea Holdings Inc, a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum.